Wiley Bros. Aintree Capital, LLC Thermo Fisher Scientific Inc. Transaction History

Wiley Bros. Aintree Capital, LLC

  • $8.04 Billion
  • Q4 2024

A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 11,968 shares of TMO stock, worth $6.37 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,968
Previous 8,645 38.44%
Holding current value
$6.37 Million
Previous $5.35 Million 16.44%
% of portfolio
0.08%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$501.29 - $612.85 $1.67 Million - $2.04 Million
3,323 Added 38.44%
11,968 $6.23 Million
Q3 2024

Nov 14, 2024
BUY
$531.86 - $624.21 $2.8 Million - $3.28 Million
5,260 Added 155.39%
8,645 $5.35 Million
Q2 2024

Jul 23, 2024
BUY
$541.52 - $599.02 $1.18 Million - $1.3 Million
2,170 Added 178.6%
3,385 $1.87 Million
Q1 2024

Apr 11, 2024
SELL
$528.82 - $599.43 $138,550 - $157,050
-262 Reduced 17.74%
1,215 $706,000
Q4 2023

Jan 08, 2024
BUY
$431.41 - $532.94 $276,965 - $342,147
642 Added 76.89%
1,477 $783,000
Q3 2023

Oct 06, 2023
BUY
$498.29 - $574.41 $34,880 - $40,208
70 Added 9.15%
835 $422,000
Q1 2023

Apr 05, 2023
BUY
$535.0 - $604.82 $14,445 - $16,330
27 Added 3.66%
765 $440,000
Q4 2022

Jan 10, 2023
SELL
$484.71 - $571.37 $44,108 - $51,994
-91 Reduced 10.98%
738 $0
Q3 2022

Oct 11, 2022
SELL
$507.19 - $604.49 $6,593 - $7,858
-13 Reduced 1.54%
829 $420,000
Q1 2022

Apr 26, 2022
BUY
$524.0 - $644.92 $4,716 - $5,804
9 Added 1.08%
842 $497,000
Q1 2022

Apr 11, 2022
BUY
$524.0 - $644.92 $10,480 - $12,898
20 Added 2.46%
833 $492,000
Q2 2021

Jul 12, 2021
BUY
$441.0 - $508.24 $5,733 - $6,607
13 Added 1.63%
813 $410,000
Q1 2021

Apr 09, 2021
BUY
$439.85 - $518.83 $57,180 - $67,447
130 Added 19.4%
800 $365,000
Q4 2020

Jan 11, 2021
SELL
$435.06 - $527.66 $13,051 - $15,829
-30 Reduced 4.29%
670 $312,000
Q3 2020

Oct 05, 2020
SELL
$359.77 - $441.52 $35,977 - $44,152
-100 Reduced 12.5%
700 $309,000
Q2 2020

Jul 07, 2020
BUY
$275.2 - $362.34 $23,116 - $30,436
84 Added 11.73%
800 $290,000
Q1 2020

Apr 03, 2020
SELL
$255.3 - $340.05 $25,530 - $34,005
-100 Reduced 12.25%
716 $203,000
Q4 2019

Jan 10, 2020
SELL
$271.93 - $328.04 $27,193 - $32,804
-100 Reduced 10.92%
816 $265,000
Q3 2019

Oct 10, 2019
BUY
$268.46 - $305.43 $245,909 - $279,773
916 New
916 $267,000
Q3 2019

Oct 04, 2019
SELL
$268.46 - $305.43 $270,070 - $307,262
-1,006 Closed
0 $0
Q2 2019

Jul 10, 2019
SELL
$257.51 - $295.55 $36,051 - $41,377
-140 Reduced 12.22%
1,006 $295,000
Q1 2019

Apr 08, 2019
BUY
$212.17 - $273.72 $243,146 - $313,683
1,146 New
1,146 $314,000

Others Institutions Holding TMO

# of Institutions
2,872
Shares Held
341M
Call Options Held
2.16M
Put Options Held
3.05M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $208B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email